Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5‐Year French National Survey
Alimentary Pharmacology & Therapeutics · 2025
DOI: 10.1111/apt.18330 ↗At a glance
Multizentrische Studie in Alimentary Pharmacology & Therapeutics, 2025. Written by Nicolas Benech and 19 co-authors. Institution: French Faecal Transplant Group (GFTF), France. Major MEDLINE topics: Fecal Microbiota Transplantation, Clostridium Infections. Cited 13 times so far (Crossref); 39 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
Detailed comparative assessment of procedure‐related factors associated with faecal microbiota transplantation (FMT) efficacy in Clostridioides difficile infection (CDI) is limited.
Aims
We took advantage of the differences in procedures at the various French FMT centres to determine clinical and procedure‐related factors associated with FMT success in CDI.
Methods
We performed a nationwide retrospective multicentre cohort study. All FMTs performed within The French Faecal Transplant Group for CDI from 2018 to 2022 were included. Clinical data were collected retrospectively from recipient medical files, characteristics of stool transplant preparations were prospectively collected by each Pharmacy involved. Univariate and multivariate analyses were performed using Fisher's test and multiple logistic regression.
Results
Six hundred fifty‐eight FMTs were performed for 617 patients in 17 centres. The overall efficacy of FMT was 84.3% (520/617), with 0.5% of severe adverse events possibly related to FMT (3/658). Forty‐seven patients were treated at the first recurrence of CDI with a similar success rate (85.1%). Severe chronic kidney disease (CKD; OR: 2.18, 95%CI [1.20–3.88]), non‐severe refractory CDI (OR: 15.35, [1.94–318.2]), the use of ≥ 80% glycerol (OR: 2.52, [1.11–5.67]), insufficient bowel cleansing (OR: 5.47, [1.57–20.03]) and partial FMT retention (OR: 9.97, [2.62–48.49]) were associated with CDI recurrence within 8 weeks.
Conclusions
Conditions of transplant manufacturing, bowel cleansing, and a route of delivery tailored to the patient's characteristics are key factors in optimising FMT efficacy. FMT at first recurrence showed high success in real‐life practice, whereas it had lower efficacy in severe CDI and non‐severe refractory CDI.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- French Faecal Transplant Group (GFTF), France.
- Hepato-Gastroenterology Department, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France.
- Lyon GEM Microbiota Study Group, Lyon, France.
- ESGHAMI (ESCMID Study Group for Host and Microbiota Interactions), Basel, Switzerland.
- Claude Bernard Lyon 1 University, CRCL, Lyon, France.
- ESGCD (ESCMID Study Group for Clostridioides difficile), Basel, Switzerland.
ORCID profiles: Nicolas Benech, Chloé Melchior, Bénédicte Pigneur, Harry Sokol
Cite
APA
Benech, N., Cassir, N., Alric, L., Barbut, F., Batista, R., Bleibtreu, A., Briot, T., Davido, B., Galperine, T., Joly, A. C., Kapel, N., Melchior, C., Mosca, A., Nebbad, B., Pigneur, B., Schneider, S. M., Wasiak, M., Scanzi, J., Sokol, H., & French Faecal Transplant Group (GFTF) (2025). Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5‐Year French National Survey. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18330
Vancouver
Benech N, Cassir N, Alric L, Barbut F, Batista R, Bleibtreu A, et al. Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5‐Year French National Survey. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.18330
BibTeX
@article{Benech2025,
author = {Benech, Nicolas and Cassir, Nadim and Alric, Laurent and Barbut, Frédéric and Batista, Rui and Bleibtreu, Alexandre and Briot, Thomas and Davido, Benjamin and Galperine, Tatiana and Joly, Anne-Christine and Kapel, Nathalie and Melchior, Chloé and Mosca, Alexis and Nebbad, Biba and Pigneur, Bénédicte and Schneider, Stéphane M and Wasiak, Mathieu and Scanzi, Julien and Sokol, Harry and French Faecal Transplant Group (GFTF), French Faecal Transplant Group (GFTF)},
title = {Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5‐Year French National Survey},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2025},
doi = {10.1111/apt.18330}
}
EUVIMED